Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a radical method of chronic myeloid leukemia (CML) treatment. In the 1990s CML became the most frequent indication for allo-HSCT worldwide. CML treatment drastically changed after tyrosine kinase inhibitors (TKI) had been introduced i...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Elena Vladislavovna Morozova, Yu. Yu. Vlasova, M. V. Barabanshchikova, N. N. Mamaev, I. M. Barkhatov, A. L. Alyanskii, E. I. Darskaya, M. V. Vladovskaya, S. N. Bondarenko, I. S. Moiseev, B. V. Afanasyev
Médium:	Artigo
Jazyk:	Russo
Vydáno:	Practical Medicine Publishing House 2020-04-01
Edice:	Клиническая онкогематология
Témata:	allo-hsct chronic myeloid leukemia tki
On-line přístup:	https://bloodjournal.ru/index.php/coh/article/view/248
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

Podobné jednotky